The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 492.13% and ...

A new study found that getting eight hours of sleep a night can "significantly" improve the ability to learn a new language, ...

Learn about clinical trials, from preclinical studies to Phase IV trials. Explore the different clinical trial phases (I-III) ...